# FDA 483 - Richard H. Hass, M.D. - May 13, 2022

Source: https://www.keypedia.com/records/483/richard-h-hass-md/e16fc0db-4348-4549-b3b9-da1d7111dfc5

> FDA 483 for Richard H. Hass, M.D. on May 13, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Richard H. Hass, M.D.
- Inspection Date: 2022-05-13
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Richard H. Haas, M.D., a Sponsor Investigator in La Jolla, CA, was cited for inadequate investigational drug disposition records during an FDA inspection. The inspection revealed discrepancies between dispensed drug quantities and subject maintenance dose logs, as well as incomplete records for the destruction of returned investigational drug kits. These findings indicate significant issues with drug accountability and record-keeping in clinical trials.

## Related Officers

- [Julian C. Hanson](https://www.keypedia.com/people/julian-c-hanson/489e27d9-0de6-4bf0-8aec-e5d500841f52)
- [investigator](https://www.keypedia.com/people/cheron-m-portee/c2cf139d-e4ce-400d-893e-bd733b3ec3a9)

Company: https://www.keypedia.com/companies/richard-h-hass-md/96afefa8-3083-4b57-8ac4-9cbabf1a0a2d

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6